Eli Lilly and Company (NYSE:LLY) Shares Acquired by Marcum …

Jan 15, 2025 · Marcum Wealth LLC lifted its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 6.6% in the fourth quarter, according to its most recent filing …

CouponFollow Extension

6%
OFF

Eli Lilly And Company (NYSE:LLY) Shares Acquired By Marcum …

3 weeks from now

Jan 15, 2025 · Marcum Wealth LLC lifted its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 6.6% in the fourth quarter, according to its most recent filing …

modernreaders.com

5%
OFF

Marcum Wealth LLC Boosts Stock Position In Eli Lilly And Company …

3 weeks from now

Oct 11, 2024 · Marcum Wealth LLC grew its holdings in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 8.5% in the third quarter, according to its most recent filing with …

tickerreport.com

5%
OFF

Bensler LLC Acquires 1,344 Shares Of Eli Lilly And Company …

3 weeks from now

23 hours ago · Bensler LLC grew its holdings in Eli Lilly and Company (NYSE:LLY - Free Report) by 9.5% in the fourth quarter, according to the company in its most recent 13F filing with the …

marketbeat.com

5%
OFF

Marcum Wealth LLC Buys 247 Shares Of Eli Lilly And Company …

3 weeks from now

Oct 11, 2024 · Marcum Wealth LLC boosted its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 8.5% in the third quarter, according to its most recent Form 13F …

defenseworld.net

7%
OFF

Heirloom Wealth Management Acquires 700 Shares Of Eli Lilly And …

3 weeks from now

2 days ago · Heirloom Wealth Management boosted its stake in Eli Lilly and Company (NYSE:LLY - Free Report) by 8.7% during the 4th quarter, according to the company in its most recent …

marketbeat.com

$57
OFF

Lilly Completes Acquisition Of Morphic To ... - Eli Lilly And Company

3 weeks from now

Aug 16, 2024 · Lilly's tender offer to acquire all of the issued and outstanding shares of common stock of Morphic (the "Shares"), at a purchase price of $57 per Share, net to the stockholder in …

lilly.com

36%
OFF

News Release - Eli Lilly And Company

3 weeks from now

Aug 8, 2024 · Revenue in Q2 2024 increased 36%, driven by Mounjaro, Zepbound and Verzenio. When excluding $579.0 million of revenue from the sale of rights for Baqsimi in Q2 2023, …

lilly.com

4%
OFF

Carnegie Investment Counsel Raises Stake In Eli Lilly And Company …

3 weeks from now

Jan 18, 2025 · Carnegie Investment Counsel grew its position in Eli Lilly and Company (NYSE:LLY - Free Report) by 16.4% during the fourth quarter, according to the company in its …

marketbeat.com

3%
OFF

Eli Lilly And Company (NYSE:LLY) Shares Acquired By Raab

3 weeks from now

Dec 9, 2024 · Raab & Moskowitz Asset Management LLC boosted its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 4.3% in the third quarter, according to the company in …

modernreaders.com

7%
OFF

Eli Lilly And Company (NYSE:LLY) Shares Acquired By ... - MarketBeat

3 weeks from now

23 hours ago · Kennedy Investment Group boosted its holdings in Eli Lilly and Company (NYSE:LLY - Free Report) by 22.7% in the fourth quarter, according to its most recent …

marketbeat.com

4%
OFF

Boston Common Asset Management LLC Raises Stock Holdings In …

3 weeks from now

Jan 19, 2025 · Boston Common Asset Management LLC grew its holdings in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 29.4% in the 4th quarter, according to the …

marketbeat.com

6%
OFF

Shelton Wealth Management LLC Increases Stock Position In Eli …

3 weeks from now

Jan 20, 2025 · Shelton Wealth Management LLC boosted its position in Eli Lilly and Company (NYSE:LLY - Free Report) by 57.6% during the 4th quarter, according to the company in its …

marketbeat.com

$1.18
OFF

872 Shares In Eli Lilly And Company (NYSE:LLY) Purchased

3 weeks from now

5 days ago · Eli Lilly and Company (NYSE:LLY - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.18 earnings per share …

marketbeat.com

$1.18
OFF

Eli Lilly And Company (NYSE:LLY) Shares Acquired By ... - MarketBeat

3 weeks from now

5 days ago · Eli Lilly and Company (NYSE:LLY - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th.The company reported $1.18 EPS for the quarter, …

marketbeat.com

08%
OFF

Eli Lilly And Company (NYSE:LLY) Shares Acquired By Merit …

3 weeks from now

Jan 19, 2025 · Eli Lilly and Company had a return on equity of 71.08% and a net margin of 20.48%. Eli Lilly and Company's revenue for the quarter was up 20.4% on a year-over-year …

marketbeat.com

$1.18
OFF

Eli Lilly And Company (NYSE:LLY) Shares Acquired By Cyndeo …

3 weeks from now

5 days ago · Eli Lilly and Company (NYSE:LLY - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.18 earnings per …

marketbeat.com

FAQs about Eli Lilly and Company (NYSE:LLY) Shares Acquired by Marcum … Coupon?

Did Eli Lilly buy dice Therapeutics?

INDIANAPOLIS, Aug. 9, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of DICE Therapeutics, Inc. (NASDAQ: DICE). ...

Does Eli Lilly have another blockbuster opportunity in the making?

Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It. | The Motley Fool Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It. Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. ...

When did Lilly's tender offer expire?

Lilly 's tender offer to acquire all of the issued and outstanding shares ("Shares") of common stock of DICE, at a purchase price of $48 per Share in cash, without interest and less any applicable tax withholding, expired as scheduled at one minute past 11:59 p.m., Eastern time, on Aug. 8, 2023 and was not further extended. ...

Is Eli Lilly building a fast-growing oncology business?

Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous opportunity, and Lilly's clinical pipeline looks well positioned. ...

Is Eli Lilly moving over mounjaro?

Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It. Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. ...

Why is Lilly a great company?

Lilly's performance and progress in Alzheimer's, metabolic disorders and many other serious diseases highlight the tenacity, focus and capability of our scientists, clinicians, engineers, customer teams and collaborators." Lilly shared numerous updates recently on key regulatory, clinical, business development and other events, including: ...